Revenue + Forward P/E
Quest Diagnostics Incorporated (DGX) quarterly revenue and forward P/EForward P/E: 20.7x
RevenueRevenue (est)Forward P/E
Fair value & valuation models
Fair value models are a Plus feature
Upgrade to Plus for the interactive DCF model, valuation bands, and implied-price scenarios.
71% OFF$23.99 $6.99/mo
Ends in23:59:59
Cancel anytime. Secure checkout via Stripe.
Valuation
Market cap
$26.24B
Enterprise value
$31.36B
P/E ratio (TTM)
24.24x
P/S ratio (TTM)
2.21x
P/B ratio
3.38x
EV/Sales
2.71x
EV/EBITDA
15.62x
Dividend yield
1.44%
Income statement (TTM)
Revenue (TTM)
$11.04B
Gross profit (TTM)
$3.52B
Operating income (TTM)
$1.60B
EBITDA (TTM)
$2.19B
Net income (TTM)
$992.00M
Free cash flow (TTM)
$1.36B
Margins & returns
Gross margin
33.15%
Operating margin
14.14%
Profit margin
9.19%
Return on equity
14.49%
Return on assets
6.27%
Per-share metrics
EPS (TTM)
$9.65
Dividend yield
1.44%
Beta
0.57
Capital structure
Cash & equivalents
$420.00M
Total debt
$6.92B
Net debt
$6.50B
Shares outstanding
110.37M
Financial health
Current ratio
1.04
Debt / equity
0.96
Debt / assets
0.43
Interest coverage
5.79
| Company | Market cap | P/E | P/S | EV/EBITDA | Div yield |
|---|---|---|---|---|---|
| $1.15T | 42.41x | 15.59x | 34.80x | 0.54% | |
| $628.65B | 30.45x | 6.47x | 20.76x | 1.99% | |
| $439.33B | 127.13x | 7.29x | 30.82x | 2.63% | |
| $368.33B | 27.06x | 0.85x | 16.46x | 2.13% | |
| $357.56B | 23.91x | 4.80x | 15.14x | 2.67% | |
| $328.31B | 36.82x | 4.94x | 19.57x | 2.56% | |
| $26.24B | 24.24x | 2.21x | 15.62x | 1.44% |